NYSE:NTRNutrien Stock Price, Forecast & News

Nutrien's stock was trading at $32.00 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, NTR stock has increased by 7.6% and is now trading at $34.43. View which stocks have been most impacted by Coronavirus.

21 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 1 sell rating, 6 hold ratings, 13 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Nutrien.

Nutrien is scheduled to release its next quarterly earnings announcement on Monday, August 3rd 2020. View our earnings forecast for Nutrien.

Nutrien Ltd (NYSE:NTR) posted its earnings results on Wednesday, May, 6th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of ($0.04) by $0.08. The business earned $4.19 billion during the quarter, compared to analysts' expectations of $3.44 billion. Nutrien had a net margin of 4.49% and a return on equity of 4.66%. The business's revenue for the quarter was up 12.6% compared to the same quarter last year. During the same period last year, the business earned $0.20 earnings per share. View Nutrien's earnings history.

Nutrien declared a quarterly dividend on Wednesday, May 6th. Shareholders of record on Tuesday, June 30th will be paid a dividend of $0.45 per share on Friday, July 17th. This represents a $1.80 annualized dividend and a yield of 5.23%. The ex-dividend date is Monday, June 29th. View Nutrien's dividend history.

Nutrien issued an update on its FY20 earnings guidance on Wednesday, May, 6th. The company provided earnings per share guidance of $1.50-2.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $2.00.

21 brokerages have issued 1 year price targets for Nutrien's shares. Their forecasts range from $36.00 to $70.00. On average, they anticipate Nutrien's share price to reach $49.50 in the next year. This suggests a possible upside of 43.8% from the stock's current price. View analysts' price targets for Nutrien.

Media coverage about NTR stock has been trending somewhat positive on Friday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand news and blog sources in real-time. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Nutrien earned a media sentiment score of 2.0 on InfoTrie's scale. They also gave media stories about the company a news buzz of 0.0 out of 10, meaning that recent media coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View the latest news aboutNutrien.

Nutrien saw a decline in short interest in the month of May. As of May 15th, there was short interest totaling 3,280,000 shares, a decline of 22.3% from the April 30th total of 4,220,000 shares. Based on an average trading volume of 2,200,000 shares, the days-to-cover ratio is presently 1.5 days. Currently, 0.6% of the company's shares are sold short. View Nutrien's Current Options Chain.

Some companies that are related to Nutrien include Scotts Miracle-Gro (SMG), CF Industries (CF), Mosaic (MOS), Nufarm (NUF), American Vanguard (AVD), Marrone Bio Innovations (MBII), Calyxt (CLXT), CVR Partners (UAN), Wynnstay Group (WYN), Arcadia Biosciences (RKDA), Evogene (EVGN), Eden Research (EDEN), Bion Environmental Technologies (BNET), China Green Agriculture (CGA) and Kiwa Bio-Tech Products Group (KWBT). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Nutrien investors own include General Electric (GE), Bank of America (BAC), Cimarex Energy (XEC), Johnson & Johnson (JNJ), Intel (INTC), AT&T (T), Exxon Mobil (XOM), Micron Technology (MU), Verizon Communications (VZ) and Pfizer (PFE).

Nutrien trades on the New York Stock Exchange (NYSE) under the ticker symbol "NTR."

Nutrien's stock is owned by a number of institutional and retail investors. Top institutional investors include First Eagle Investment Management LLC (3.99%), CIBC Asset Management Inc (1.42%), Mackenzie Financial Corp (1.29%), 1832 Asset Management L.P. (1.22%), Capital International Investors (1.19%) and The Manufacturers Life Insurance Company (1.08%).

NTR stock was sold by a variety of institutional investors in the last quarter, including Wellington Management Group LLP, 1832 Asset Management L.P., Capital Research Global Investors, Invesco Ltd., Schroder Investment Management Group, Capital International Investors, Alberta Investment Management Corp, and Morgan Stanley.

NTR stock was purchased by a variety of institutional investors in the last quarter, including The Manufacturers Life Insurance Company , State Street Corp, AGF Investments Inc., 1832 Asset Management L.P., Canada Pension Plan Investment Board, Janus Henderson Group PLC, CIBC Asset Management Inc, and Connor Clark & Lunn Investment Management Ltd..

Shares of NTR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

One share of NTR stock can currently be purchased for approximately $34.43.

Nutrien has a market capitalization of $19.62 billion and generates $20.02 billion in revenue each year. The company earns $992 million in net income (profit) each year or $2.17 on an earnings per share basis. Nutrien employs 22,300 workers across the globe.

The official website for Nutrien is www.nutrien.com.

Nutrien's mailing address is SUITE 500 122 - 1ST AVENUE SOUTH, SASKATOON A9, S7K 7G3. The company can be reached via phone at 306-933-8500 or via email at [email protected]